Vilchez, Regis A.,Rodrigues Jr., Lino,Bernstein, Barry M.,Podsadecki, Thomas J.,Brun, Scott C.,Cohen, Daniel E.,Menon, Rajeev M.,Khatri, Amit,Mensing, Sven,Dutta, Sandeep,Awni, Walid M.,Dumas, Emily O
申请号：
AU2014284455
公开号：
AU2014284455A1
申请日:
2014.07.01
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention features interferon-free therapies for treating HCV genotype 1b, 2, 3 or 4. In one aspect, the therapies comprise administering Compound 1, ritonavir, and Compound 2 to a subject infected with HCV genotype 1b or 4, wherein the therapies do not include administration of any interferon, and the therapies last for 12 weeks. Preferably, the therapies do not include administration of any ribavirin.
